Gene expression and association analysis of vascular endothelial growth factor in major depressive disorder

[1]  Hongwei Song,et al.  Gene expression and association analysis of LIM (PDLIM5) in major depression , 2006, Neuroscience Letters.

[2]  Chaeyoung Lee,et al.  Haplotype analysis of single nucleotide polymorphisms in VEGF gene for vascular dementia , 2006, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[3]  Hongwei Song,et al.  Serotonin transporter mRNA expression in peripheral leukocytes of patients with major depression before and after treatment with paroxetine , 2005, Neuroscience Letters.

[4]  R. Carney,et al.  Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction. , 2005, Archives of general psychiatry.

[5]  R. Hubbard,et al.  General population based study of the impact of tricyclic and selective serotonin reuptake inhibitor antidepressants on the risk of acute myocardial infarction , 2005, Heart.

[6]  M. Joëls,et al.  Chronic stress in the adult dentate gyrus reduces cell proliferation near the vasculature and VEGF and Flk‐1 protein expression , 2005, The European journal of neuroscience.

[7]  D. Galimberti,et al.  Vascular endothelial growth factor gene variability is associated with increased risk for AD , 2005, Annals of neurology.

[8]  M. Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[9]  C. Gazzaruso,et al.  Decreased Release of the Angiogenic Peptide Vascular Endothelial Growth Factor in Alzheimer’s Disease: Recovering Effect with Insulin and DHEA Sulfate , 2004, Dementia and Geriatric Cognitive Disorders.

[10]  R. Duman,et al.  Gene Profile of Electroconvulsive Seizures: Induction of Neurotrophic and Angiogenic Factors , 2003, The Journal of Neuroscience.

[11]  C. Nemeroff,et al.  Epidemiology of comorbid coronary artery disease and depression , 2003, Biological Psychiatry.

[12]  K. Jin,et al.  VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia. , 2003, The Journal of clinical investigation.

[13]  N. Ferrara,et al.  The biology of VEGF and its receptors , 2003, Nature Medicine.

[14]  J. Zentner,et al.  Implications of Vascular Endothelial Growth Factor, sFlt-1, and sTie-2 in Plasma, Serum and Cerebrospinal Fluid during Cerebral Ischemia in Man , 2003, Journal of Cerebral Blood Flow and Metabolism.

[15]  A. Larsson,et al.  VEGF is increased in serum but not in spinal cord from patients with amyotrophic lateral sclerosis , 2002, Neuroreport.

[16]  P. Rocca,et al.  Decrease of the D4 dopamine receptor messenger RNA expression in lymphocytes from patients with major depression , 2002, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[17]  Anders Wallin,et al.  Increased intrathecal levels of the angiogenic factors VEGF and TGF-β in Alzheimer’s disease and vascular dementia , 2002, Neurobiology of Aging.

[18]  G. Lip,et al.  Plasma vascular endothelial growth factor and its receptor Flt-1 in patients with hyperlipidemia and atherosclerosis and the effects of fluvastatin or fenofibrate. , 2001, The American journal of cardiology.

[19]  G. Lip,et al.  Measurement of free and complexed soluble vascular endothelial growth factor receptor, Flt-1, in fluid samples: development and application of two new immunoassays. , 2001, Clinical science.

[20]  T. Palmer,et al.  Vascular niche for adult hippocampal neurogenesis , 2000, The Journal of comparative neurology.

[21]  T. Soeki,et al.  Serial Changes in Serum VEGF and HGF in Patients with Acute Myocardial Infarction , 2000, Cardiology.

[22]  K. Kugiyama,et al.  Increased Blood Vascular Endothelial Growth Factor Levels in Patients with Acute Myocardial Infarction , 2000, Cardiology.

[23]  E. Kohner,et al.  Levels of vascular endothelial growth factor are elevated in the vitreous of patients with subretinal neovascularisation. , 1996, The British journal of ophthalmology.

[24]  Edgar Erdfelder,et al.  GPOWER: A general power analysis program , 1996 .

[25]  S. Soker,et al.  Peripheral blood T lymphocytes and lymphocytes infiltrating human cancers express vascular endothelial growth factor: a potential role for T cells in angiogenesis. , 1995, Cancer research.

[26]  E. Manseau,et al.  Vascular permeability factor mRNA and protein expression in human kidney. , 1992, Kidney international.

[27]  B. Berse,et al.  Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. , 1992, Molecular biology of the cell.

[28]  J. Fiddes,et al.  The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. , 1991, The Journal of biological chemistry.

[29]  K. Jin,et al.  VEGF and ALS: the luckiest growth factor? , 2004, Trends in molecular medicine.

[30]  P. Carmeliet,et al.  VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death , 2003, Nature Genetics.